Past event: Prefilled Syringes West Coast Conference

Assessing Device Development and Regulation for Advanced Innovation

Our 7th Annual Pre-Filled Syringes West Coast Conference will be back for 2023 in San Diego to bring together the device developers, innovative biotech and big pharma. This year's conference will explore the exciting advances in the combination product drug delivery space and a future outlook exploring how pharma, device developers and regulators can work together to encourage innovation.

With the injectable drug delivery industry rapidly advancing year-to-year, administration using pre-filled syringes, auto-injectors, and pen-injectors are increasingly common. Innovations in device technology, such as connected devices are leading the way in device design in addition to injectable delivery devices for novel and large volume drugs. With the need for self-administration growing, there is an enhanced demand for on-body injectors and digitalised health as well as patient centricity. We are beginning to see environmental sustainability being incorporated into aspects of device lifecycle from design to manufacturing and the use of the device. This year's conference looks to address these hot topics through case studies and industry insights.

As part of our leading injectable drug delivery conferences this is a must attend event; not only will the conference bring you key insights to enhance your drug device portfolio, but it will also give you the opportunity to network with key industry players. We hope to welcome you in June 2023!

Benefits of Attending

  • Engage with industry representatives about the latest technologies and advances within the injectable device market and directions to take to advance your device portfolio
  • Gain insight into new technologies for wearable injectors he delivery of novel and large volume drugs
  • Understand the latest regulatory requirements and guidance to ensure your combination products are compliant such as meeting essential performance requirements
  • Delve into aspects of primary packaging such as material components to consider during device design to ensure drug stability and safety
  • Explore how digital technologies such as companion apps are being incorporated into drug delivery devices to improve user-centricity

Who should attend

Directors, Heads of Departments and Managers for the following areas:
  • Device Development
  • Device Engineering
  • Combination Product Development
  • Drug Delivery Devices
  • Primary Packaging Development
  • Digital Health
  • Large Volume Drug Delivery
  • Novel Drug Product Formulation
  • Regulatory Affairs

Featured Speakers

  • Alex Baker, Senior Engineer II, Biogen
  • Amin Sedighiamiri, Associate Director Device Development, AstraZeneca
  • Angela Muriset, Director, Human Factors - Combination Product Development, AbbVie
  • Aslin M. Rodriguez Nassif, Senior Scientist, Pfizer, Inc.
  • Cecile Gross, Category Manager Parenteral, Nemera
  • Daniel Branco, Digital Health in Omnichannel, Ionis Pharmaceuticals
  • David Morra, Director, Devices and Digital Health, Merck, Sharpe, & Dohme
  • Doug Bryans, President and CEO, Bryllan LLC
  • Frank Leipold, VP Product Management, Haselmeier GmbH
  • Gabrielle Gehron, Scientific Support Manager, Datwyler
  • Gary Burns, Founder at eAgile, eAgile a CCL Healthcare company
  • Jeanne Greathouse, Global Director Healthcare, BSI Group
  • John Merhige, CEO, Credence MedSystems
  • Karthik Vaideeswaran, Associate Vice President, Eli Lilly And Company
  • Khaudeja Bano, Vice President, Combination Product Quality, Amgen
  • Larry Atupem, Business Development Manager, Zeon Specialty Materials
  • Natalie Abts, Head of Human Factors Engineering, Genentech
  • Nicholas Mandala, Senior Director, Combination Products and Device Engineering, Pfizer
  • Porsche Bennett, Acting Team Lead, General Hospital Team, Food and Drug Administration
  • Ravi Kaushik, Vice President, Patient Integrated Care Innovation Platform, Takeda Pharmaceuticals
  • Scott Nunn, Director, Device Development, Gilead Sciences, Inc
  • Shota Arakawa, Researcher , Mitsubishi Gas Chemical Company, Inc
  • Shrikar Tatapudi, Human Factors Engineer, UserWise
  • Son Tran, Associate Director, Device Engineering, Gilead Sciences
  • Speaker to be confirmed, Credence MedSystems
  • Tina Rees, Associate Director, Human Factors, Regeneron Pharmaceuticals
  • Yusuf Oni, Associate Director, Bristol Myers Squibb

Please fill in your name and email to receive the Conference Agenda of this event.


Horton Grand Hotel
311 Island Ave, 92101
San Diego, CA, USA

Event details
Organizer : SAE Media Group
Event type : Conference
Reference : ASDE-24223